T. Rowe Price Associates’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

T. Rowe Price Associates’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,804	Closed	-$321K	–	3186
2025 Q1	$321K	Buy	17,804 +2,263	+15%	+$40.2K	﹤0.01%	2437
2024 Q4	$272K	Buy	15,541 +2,573	+20%	+$34.8K	﹤0.01%	2556
2024 Q3	$150K	Buy	12,968 +207	+2%	+$2.38K	﹤0.01%	2748
2024 Q2	$145K	Buy	12,761 +1,317	+12%	+$17.5K	﹤0.01%	2673
2024 Q1	$164K	Buy	+11,444	New	+$162K	﹤0.01%	2676

T. Rowe Price Associates's PTVE Position: Q2 2025 in Review

T. Rowe Price Associates sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 17,804 shares — an estimated $321K sold.

T. Rowe Price Associates first reported a position in PTVE in Q1 2024 and held it in 5 quarters. The position peaked at $321K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

T. Rowe Price Associates reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
T. Rowe Price Associates sold 17,804 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $321K.
T. Rowe Price Associates first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2024 and held it in 5 quarters.
T. Rowe Price Associates's Pactiv Evergreen Inc. Common stock position peaked at $321K in Q1 2025.
0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.